-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, UOD2Oqh74VNYbji9pBAylpATMyerh2gF10WO0cD3chcHldgmuNl24R1ZwnKZktWb m1aSQu2tOzzanIC6ekQwrg== 0000912057-02-005996.txt : 20020414 0000912057-02-005996.hdr.sgml : 20020414 ACCESSION NUMBER: 0000912057-02-005996 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20020214 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: SIEGALL CLAY B CENTRAL INDEX KEY: 0001167496 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: 21823 30TH DRIVE SE CITY: BOTHELL STATE: WA ZIP: 98021 BUSINESS PHONE: 4255274000 MAIL ADDRESS: STREET 1: 21823 30TH DR SE CITY: BOTHELL STATE: WA ZIP: 98021 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: SEATTLE GENETICS INC /WA CENTRAL INDEX KEY: 0001060736 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 911874389 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-61317 FILM NUMBER: 02545602 BUSINESS ADDRESS: STREET 1: 22215 26TH AVENUE S E STREET 2: SUITE 3000 CITY: BOTHELL STATE: WA ZIP: 98021 BUSINESS PHONE: 4254894990 MAIL ADDRESS: STREET 1: 22215 26TH AVENUE S E STREET 2: SUITE 3000 CITY: BOTHELL STATE: WA ZIP: 98021 SC 13G 1 a2070927zsc13g.htm FORM 13G Prepared by MERRILL CORPORATION
QuickLinks -- Click here to rapidly navigate through this document
    UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

Under the Securities Exchange Act of 1934
(Amendment No.          )*		  
OMB APPROVAL
OMB Number: 3235-0145
Expires: October 31, 2002
Estimated average burden
hours per response. . . 14.9

SEATTLE GENETICS, INC.
(Name of Issuer)

COMMON STOCK
(Title of Class of Securities)

 
 
812578102
 
 
   
(CUSIP Number)		    

DECEMBER 31, 2001
(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

        / /      Rule 13d-1(b)

        / /      Rule 13d-1(c)

        /x/      Rule 13d-1(d)

*The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

CUSIP No.            812578102        

             
1   NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

 
 
CLAY B. SIEGALL
 
 
 
 
2   CHECK THE APPROPRIATE BOX IF A   (a)   / /
    MEMBER OF A GROUP   (b)   / /
    (See Instructions)        

 
 
 
 
 
 
 
3   SEC USE ONLY

 
 
 
 
 
 
 
4   CITIZENSHIP OR PLACE OF ORGANIZATION

 
 
UNITED STATES
 
 
 
 
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH:   5   SOLE VOTING POWER
            1,717,500
       
        6   SHARED VOTING POWER

 
 
 
 
 
 
 
       
        7   SOLE DISPOSITIVE POWER

 
 
 
 
 
 
1,717,500
       
        8   SHARED DISPOSITIVE POWER

 
 
 
 
 
 
 
9   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 
 
1,717,500
 
 
 
 
10   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See Instructions)

 
 
 
 
 
 
 
11   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

 
 
5.86%
 
 
 
 
12   TYPE OF REPORTING PERSON (See Instructions)

 
 
IN
 
 
 
 

Item 1(a).    Name of Issuer:

        Seattle Genetics, Inc.

Item 1(b).    Address of Issuer's Principal Executive Offices:

        21823 - 30th Drive S.E. Bothell, WA 98021

Item 2(a).    Name of Person Filing:

        Clay B. Siegall

Item 2(b).    Address of Principal Business Office or, if none, Residence:

        21823 - 30th Drive S.E. Bothell, WA 98021

Item 2(c).    Citizenship:

        United States of America

Item 2(d).    Title of Class of Securities:

        Common Stock

Item 2(e).    CUSIP Number:

        812578102

Item 3.    If this statement is filed pursuant to Rule 13d-1(b), 13d-2(b) or 13d-2(c), check whether the person filing is a:

        Not Applicable

Item 4.    Ownership.

    (a)
    Amount Beneficially Owned:

        1,717,500

    (b)
    Percent of Class:

        5.86%

    (c)
    Number of shares as to which such person has:

    (i)
    Sole power to vote or to direct the vote:    1,717,500

    (ii)
    Shared power to vote or to direct the vote:    -0-

    (iii)
    Sole power to dispose or to direct the disposition of:    1,717,500

    (iv)
    Shared power to dispose or to direct the disposition of:    -0-

Item 5.    Ownership of Five Percent or Less of a Class.

        Not Applicable

Item 6.    Ownership of More than Five Percent on Behalf of Another Person.

        Not Applicable

Item 7.    Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company.

        Not Applicable

Item 8.    Identification and Classification of Members of the Group.

        Not Applicable

Item 9.    Notice of Dissolution of Group.

        Not Applicable

Item 10.    Certification.


SIGNATURE

        After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     

 
 
February 14, 2002
Date
     

 
 
/s/  CLAY B. SIEGALL      
Signature
     

 
 
CLAY B. SIEGALL
PRESIDENT & CHIEF SCIENTIFIC OFFICER
Name/Title


QuickLinks

SIGNATURE
 -----END PRIVACY-ENHANCED MESSAGE-----